Richard Cunningham is an agile, analytical leader, with a penchant for bringing energy, considered risk-taking and creative solutions to tough commercial paths. Specialized in Market Access and Pricing, he is comfortable across lifecycle stages and therapeutic areas. An accomplished leader, with domestic and international experience, he has developed nimble, high-performing teams at McKesson, Sanofi and Pfizer. In his current role, as Vice President of Pricing for McKesson's healthcare technology division, CoverMyMeds, he has broad responsibility for pricing and contracting, with an emphasis on margin optimization and profit creation. Previously, as Global Pricing Head (Executive Director) at Sanofi, he led a team responsible for pricing in North America and for Vaccines, globally. In his prior role as Senior Director of Market Access at Pfizer, he was responsible for driving innovation in business models to improve patient access and affordability. He has held progressive roles including Internal Audit, Commercial Strategy, Competitive Intelligence, Field Force Effectiveness, FP&A and, most recently, Market Access & Pricing.Through an early career in Languages and Journalism, he has developed a dexterity in communications, which now serves him in guiding responsible decision-making, through influence.He holds an MBA in Finance from the University of Edinburgh, a Bachelors in Spanish & Portuguese from the University of Leeds and Professional Certificate​s in Health Economics​, from the University of Chicago​, and Executive Leadership, from Cornell University.Additionally, he is a Certified Management Accountant (CMA) and currently serves on the Board of Regents for the Institute of Management Accountants.